Efficacy of a drug named probiotics in treating acute diarrhoea in adults
Not Applicable
- Conditions
- Health Condition 1: null- acute diarrhoea
- Registration Number
- CTRI/2018/04/013360
- Lead Sponsor
- Dr Meera Baby John
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients above 14years who have acute diarrhea
Exclusion Criteria
acute diarrhea who also have a serious complication ( renal failure , metabolic acidosis , severe dehydration , hypovolemic shock , heart failure)
History of allergy to lactobacillus spp.
H/o diarrhoea caused by amoeba (as evidenced by demonstration of motile trophozoites with blood in stool)colorectal cancer (as diagnosed by a per rectal examinationand/or endoscopic procedures where necessary).
Known allergy to study drugs
Patients who are already on probiotics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the efficacy of lactobacillus sporogenes in reducing the duration of diarrhoea in adults compared to placebo and it will be assessed for 7 daysTimepoint: To determine the efficacy of lactobacillus sporogenes in reducing the duration of diarrhoea in adults compared to placebo and it will be assessed for 7 days
- Secondary Outcome Measures
Name Time Method To establish the efficacy of lactobacillus sporogenes in reducing the frequency of loose stools,abdominal pain and hospital stay compared to placebo in adults with diarrhoeaTimepoint: 2 years